HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
DXCM
Dexcom Inc
Healthcare Medical Devices · California, USA · Reports in usd
Market Cap: $23.14B
Market Cap
$23.14B
Enterprise Val
$22.47B
P/E Ratio
27.66
P/B Ratio
8.43
Trailing PEG (1Y)
0.34
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$2.75B
Gross Margin62.93%
Profit Margin62.93%
Return on Equity32.44%
Return on Assets11.98%
Current Ratio1.88
Debt/Equity0.49
LT Debt/Equity0.48
Revenue Per Share3.23

Income Statement

Dec 31, 2025
Revenue$1.26B
Cost of Revenue$466.9M
Gross Profit$792.7M
R&D$148.2M
SG&A$321.5M
Operating Expenses$469.7M
Operating Income$323.0M
Interest Expense$18.3M
Tax Expense$73.4M
Net Income$267.3M
EPS (Basic)$0.69
EPS (Diluted)$0.67
EBIT$359.0M
EBITDA$424.2M
Consolidated Income$267.3M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$917.7M
Accounts Receivable$1.22B
Inventory$629.1M
Current Assets$4.03B
LT Investments$0.00
Property, Plant & Equipment$1.64B
Intangibles$95.0M
Non-Current Assets$2.31B
Total Assets$6.34B
Accounts Payable$1.94B
Current Debt$21.6M
Current Liabilities$2.14B
LT Debt$1.31B
Non-Current Liabilities$1.45B
Total Liabilities$3.59B
Total Debt$1.34B
Retained Earnings$2.43B
Shareholder Equity$2.75B
Shares Outstanding390,016,272

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$294.0M
Investing Cash Flow$306.6M
Financing Cash Flow-$1.52B
CapEx-$101.9M
Free Cash Flow$192.1M
Depreciation & Amort.$65.2M
Stock-Based Comp$35.0M
Acquisitions / Disposals$0.00
Investment Activity$408.4M
Debt Issued/Repaid-$1.21B
Equity Issued/Repaid-$312.8M
Dividends Paid$0.00
Net Change in Cash-$917.8M
Data cached · Meta live · Daily live · Statements live · TTL 24h